tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Boobalan Pachaiyappan, 36 are a BUY (100%).
Analyst Boobalan Pachaiyappan, currently employed at ROTH MKM, carries an average stock price target met ratio of 25.71% that have a potential upside of 27.55% achieved within 53 days. Previously, Boobalan Pachaiyappan worked at HC WAINWRIGHT.
Boobalan Pachaiyappan’s has documented 71 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CING, Cingulate at 23-Mar-2026.
Analyst best performing recommendations are on CAPR (CAPRICOR THERAPEUTICS).
The best stock recommendation documented was for CAPR (CAPRICOR THERAPEUTICS) at 11/12/2025. The price target of $13 was fulfilled within 21 days with a profit of $7.13 (121.47%) receiving and performance score of 57.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Jun-2025
$63
$36.56 (138.28%)
$50
4 months 2 days ago
(13-Mar-2026)
1/3 (33.33%)
$32.5 (106.56%)
160
Buy Since 21-Oct-2024
$58
$31.56 (119.36%)
$45
4 months 2 days ago
(13-Mar-2026)
2/5 (40%)
$27.5 (90.16%)
520
Buy Since 15-Sep-2017
$60
4 months 2 days ago
(13-Mar-2026)
10/20 (50%)
$26.6 (79.64%)
614
Buy Since 17-May-2024
$54
$27.56 (104.24%)
$22
7 months 7 days ago
(08-Dec-2025)
5/6 (83.33%)
$25.44 (89.08%)
91
Buy Since 29-Apr-2020
$50
$23.56 (89.11%)
$25
7 months 11 days ago
(04-Dec-2025)
7/8 (87.5%)
$24.6 (96.85%)
616
Which stock is Boobalan Pachaiyappan is most bullish on?
Which stock is Boobalan Pachaiyappan is most reserved on?
What Year was the first public recommendation made by Boobalan Pachaiyappan?
